Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
$0.83
-1.2%
$0.85
$0.55
$1.66
$106.82M0.9760,248 shs468,255 shs
Endologix, Inc. stock logo
ELGX
Endologix
$0.07
$0.03
$0.22
$7.10
$1.41M0.731.28 million shs85,372 shs
Neovasc Inc. stock logo
NVCN
Neovasc
$30.03
$29.69
$4.59
$30.07
$82.28M1.756,993 shs1 shs
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
$0.73
$0.52
$11.14
$3.19M-0.03197,480 shs77,500 shs
Titan Medical Inc. stock logo
TMDI
Titan Medical
$0.14
-26.3%
$0.23
$0.13
$1.20
$15.67M2.364.83 million shs7.71 million shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
-1.21%-5.74%-2.96%+37.58%-29.32%
Endologix, Inc. stock logo
ELGX
Endologix
0.00%0.00%0.00%0.00%0.00%
Neovasc Inc. stock logo
NVCN
Neovasc
0.00%0.00%0.00%0.00%0.00%
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
0.00%0.00%0.00%0.00%0.00%
Titan Medical Inc. stock logo
TMDI
Titan Medical
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
1.4925 of 5 stars
3.71.00.00.00.61.70.0
Endologix, Inc. stock logo
ELGX
Endologix
N/AN/AN/AN/AN/AN/AN/AN/A
Neovasc Inc. stock logo
NVCN
Neovasc
N/AN/AN/AN/AN/AN/AN/AN/A
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
N/AN/AN/AN/AN/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDI
Titan Medical
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
3.33
Buy$6.17645.67% Upside
Endologix, Inc. stock logo
ELGX
Endologix
0.00
N/AN/AN/A
Neovasc Inc. stock logo
NVCN
Neovasc
0.00
N/AN/AN/A
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
0.00
N/AN/AN/A
Titan Medical Inc. stock logo
TMDI
Titan Medical
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ATOS, ELGX, RMED, NVCN, and TMDI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/6/2025
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.25 ➝ $7.50
6/5/2025
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$4.00
4/21/2025
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.00 ➝ $7.25
(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
N/AN/AN/AN/A$0.57 per shareN/A
Endologix, Inc. stock logo
ELGX
Endologix
$143.37M0.01N/AN/A$3.56 per share0.02
Neovasc Inc. stock logo
NVCN
Neovasc
$3.81M21.60N/AN/A$5.77 per share5.20
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
$10K0.00N/AN/A$4.29 per share0.00
Titan Medical Inc. stock logo
TMDI
Titan Medical
$20.09M0.78N/AN/A$0.32 per share0.44
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
-$25.50M-$0.21N/AN/AN/AN/A-33.90%-31.53%8/11/2025 (Estimated)
Endologix, Inc. stock logo
ELGX
Endologix
-$64.76M-$2.19N/AN/AN/A-44.65%-63.96%-13.26%N/A
Neovasc Inc. stock logo
NVCN
Neovasc
-$41.20M-$15.08N/AN/A-1,082.92%-127.25%-80.31%N/A
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
-$26.86M-$92.36N/AN/AN/AN/A-496.57%-344.49%N/A
Titan Medical Inc. stock logo
TMDI
Titan Medical
-$14.86M-$0.19N/AN/AN/A-167.03%-112.15%N/A

Latest ATOS, ELGX, RMED, NVCN, and TMDI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
-$0.06-$0.05+$0.01-$0.05N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
N/AN/AN/AN/AN/A
Endologix, Inc. stock logo
ELGX
Endologix
N/AN/AN/AN/AN/A
Neovasc Inc. stock logo
NVCN
Neovasc
N/AN/AN/AN/AN/A
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
N/AN/AN/AN/AN/A
Titan Medical Inc. stock logo
TMDI
Titan Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
N/A
12.67
12.67
Endologix, Inc. stock logo
ELGX
Endologix
0.29
0.39
0.28
Neovasc Inc. stock logo
NVCN
Neovasc
0.80
2.96
2.85
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
N/A
2.86
2.85
Titan Medical Inc. stock logo
TMDI
Titan Medical
N/A
1.41
1.41

Institutional Ownership

CompanyInstitutional Ownership
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
12.74%
Endologix, Inc. stock logo
ELGX
Endologix
51.61%
Neovasc Inc. stock logo
NVCN
Neovasc
1.64%
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
11.00%
Titan Medical Inc. stock logo
TMDI
Titan Medical
3.55%

Insider Ownership

CompanyInsider Ownership
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
7.60%
Endologix, Inc. stock logo
ELGX
Endologix
1.30%
Neovasc Inc. stock logo
NVCN
Neovasc
N/A
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
18.62%
Titan Medical Inc. stock logo
TMDI
Titan Medical
0.02%
CompanyEmployeesShares OutstandingFree FloatOptionable
Atossa Genetics Inc. stock logo
ATOS
Atossa Genetics
8129.17 million119.35 millionOptionable
Endologix, Inc. stock logo
ELGX
Endologix
52819.17 millionN/AOptionable
Neovasc Inc. stock logo
NVCN
Neovasc
492.74 millionN/ANot Optionable
Ra Medical Systems, Inc stock logo
RMED
Ra Medical Systems
145.37 million4.37 millionNot Optionable
Titan Medical Inc. stock logo
TMDI
Titan Medical
49111.95 million111.93 millionNot Optionable

Recent News About These Companies

Conavi Medical Corp. Commences Trading on TSX-V Under Symbol “CNVI”
Titan Submersible Hearings
Masculen Titan ME Review – Is It Really Worth Buying?
Titan Pharmaceuticals: Q1 Earnings Snapshot
TMD:CA Titan Medical Inc.
Titan Medical Inc TMDIF
Perifery appoints Titan Data Solutions as authorised distributor
Titan Medical Inc (TMD)
Vantage Titan 3T MRI Scanner from Toshiba
TMDIF Titan Medical Inc.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Atossa Genetics stock logo

Atossa Genetics NASDAQ:ATOS

$0.83 -0.01 (-1.21%)
Closing price 07/3/2025 03:56 PM Eastern
Extended Trading
$0.83 0.00 (-0.12%)
As of 07/3/2025 04:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

Endologix stock logo

Endologix NASDAQ:ELGX

Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. The company offers minimally-invasive endovascular aneurysm repair (EVAR), including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the Ovation abdominal stent graft system. It also provides endovascular aneurysm sealing system (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens. In addition, the company offers proximal aortic extensions and limb extensions, which allow physicians to customize the implant to fit the patient's anatomy; and accessories to facilitate the delivery of its EVAR and EVAS products, including compatible guidewires, inflation devices, and snares. It sells its products through direct sales force, and a network of third party distributors and agents. The company was formerly known as Radiance Medical Systems, Inc. and changed its name to Endologix, Inc. in May 2002. Endologix, Inc. was founded in 1992 and is headquartered in Irvine, California.

Neovasc stock logo

Neovasc NASDAQ:NVCN

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.

Ra Medical Systems stock logo

Ra Medical Systems NYSE:RMED

Ra Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina.

Titan Medical stock logo

Titan Medical NASDAQ:TMDI

Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.